DrugPatentWatch Database Preview
Profile for World Intellectual Property Organization (WIPO) Patent: 2005012242
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2005012242
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Jul 14, 2027 | Janssen Pharms | INVOKAMET XR | canagliflozin; metformin hydrochloride |
➤ Try a Free Trial | Jul 14, 2027 | Janssen Pharms | INVOKAMET | canagliflozin; metformin hydrochloride |
➤ Try a Free Trial | Jul 14, 2027 | Janssen Pharms | INVOKANA | canagliflozin |
➤ Try a Free Trial | Jul 30, 2024 | Janssen Pharms | INVOKAMET XR | canagliflozin; metformin hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |